Lira, Jiaden .

HRN: 24-26-57  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2023
CEFTRIAXONE 1G (VIAL)
12/20/2023
12/27/2023
IV
610mg
Q24
PCAP C
Waiting Final Action 
12/21/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
12/21/2023
12/27/2023
PO
1.5ml
OD
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: